Lukas Scheibler
22Patents
7h-index
21Co-inventors
69Inventor score
Filing activity: May 23, 2002 → Nov 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6730319B2 | Pharmaceutical compositions having depressed melting points | Human Necessities | 55 | Expired |
| US10610096B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Electricity | 30 | Active |
| US10952607B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Electricity | 17 | Active |
| US11357401B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Human Necessities | 12 | Active |
| US10159566B2 | Heat tunable intraocular lens | Human Necessities | 8 | Active |
| US11576572B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Human Necessities | 8 | Active |
| US11627874B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Electricity | 7 | Active |
| US11896308B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Human Necessities | 2 | Active |
| US11890053B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Electricity | 2 | Active |
| US9604949B2 | Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension | Chemistry; Metallurgy | 1 | Active |
| US11510939B1 | RNAs for complement inhibition | Chemistry; Metallurgy | 1 | Active |
| US8039508B2 | Lipase inhibiting composition | Human Necessities | 1 | Active |
| US8343543B2 | Lipase inhibiting composition | Human Necessities | 0 | Active |
| US12396843B2 | Heat tunable intraocular lens | Human Necessities | 0 | Active |
| US12128104B2 | Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor | Human Necessities | 0 | Active |
| US10016441B2 | Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension | Chemistry; Metallurgy | 0 | Active |
| US12290317B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Human Necessities | 0 | Active |
| US11666432B2 | Heat tunable intraocular lens | Human Necessities | 0 | Active |
| US10786348B2 | Heat tunable intraocular lens | Human Necessities | 0 | Active |
| US12396639B2 | Miniaturized mobile, low cost optical coherence tomography system for home based ophthalmic applications | Electricity | 0 | Active |
| US12251395B2 | RNAS for complement inhibition | Chemistry; Metallurgy | 0 | Active |
| US11147855B2 | Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.